Clinical trials
Recruiting Breast Carcinoma In Situ trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 3 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 3 |
| National Cancer Institute (NCI) | 3 |
| Ohio State University Comprehensive Cancer Center | 2 |
| Thomas Jefferson University | 2 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Brigham and Women's Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| PreludeDx | 1 |
| Providence Health & Services | 1 |
| Saint John's Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 20 |
| Breast Neoplasms | 10 |
| Carcinoma, Intraductal, Noninfiltrating | 8 |
| Carcinoma in Situ | 1 |
| Hypertrophy | 1 |
| Laryngeal Diseases | 1 |
| Laryngeal Neoplasms | 1 |
| Lymphoma | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.